scholarly journals A randomised, double-blind, trial of the safety and efficacy of omarigliptin (a once-weekly DPP-4 inhibitor) in subjects with type 2 diabetes and renal impairment

2017 ◽  
Vol 71 (6) ◽  
pp. e12955 ◽  
Author(s):  
Antonio Chacra ◽  
Ira Gantz ◽  
Geraldine Mendizabal ◽  
Lucila Durlach ◽  
Edward A. O'Neill ◽  
...  
The Lancet ◽  
2015 ◽  
Vol 385 (9982) ◽  
pp. 2067-2076 ◽  
Author(s):  
Faiez Zannad ◽  
Christopher P Cannon ◽  
William C Cushman ◽  
George L Bakris ◽  
Venu Menon ◽  
...  

The Lancet ◽  
2017 ◽  
Vol 389 (10077) ◽  
pp. 1399-1409 ◽  
Author(s):  
Carel W le Roux ◽  
Arne Astrup ◽  
Ken Fujioka ◽  
Frank Greenway ◽  
David C W Lau ◽  
...  

Diabetes Care ◽  
2012 ◽  
Vol 35 (6) ◽  
pp. 1249-1251 ◽  
Author(s):  
S. Brunner ◽  
I. Holub ◽  
S. Theis ◽  
A. Gostner ◽  
R. Melcher ◽  
...  

BMJ ◽  
2009 ◽  
Vol 339 (nov09 1) ◽  
pp. b4324-b4324 ◽  
Author(s):  
S. S Lund ◽  
L. Tarnow ◽  
M. Frandsen ◽  
B. B Nielsen ◽  
B. V Hansen ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document